These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 7866184)

  • 1. Severe chickenpox during treatment with corticosteroids. At what age should varicella-zoster immunoglobulin be given?
    Buss P
    BMJ; 1995 Feb; 310(6975):327; author reply 328. PubMed ID: 7866184
    [No Abstract]   [Full Text] [Related]  

  • 2. Severe chickenpox during treatment with corticosteroids. Immunoglobulin should be given if steroid dosage was > or = 0.5 mg/kg/day in preceding three months.
    Burnett I
    BMJ; 1995 Feb; 310(6975):327; author reply 328. PubMed ID: 7866185
    [No Abstract]   [Full Text] [Related]  

  • 3. Volume of varicella-zoster immune globulin.
    Marchant CD; Leszczynski J
    Pediatr Infect Dis J; 1991 Jun; 10(6):476. PubMed ID: 1649433
    [No Abstract]   [Full Text] [Related]  

  • 4. Severe chickenpox during treatment with corticosteroids. National guidelines exist.
    Ellender D; Waller P; Wood S; Rawlins M; Langman M; Salisbury D; Wilson E
    BMJ; 1995 Feb; 310(6975):327; author reply 328. PubMed ID: 7755723
    [No Abstract]   [Full Text] [Related]  

  • 5. Fatal varicella-zoster infection in a newborn treated with varicella-zoster immunoglobulin.
    King SM; Gorensek M; Ford-Jones EL; Read SE
    Pediatr Infect Dis; 1986; 5(5):588-9. PubMed ID: 3020522
    [No Abstract]   [Full Text] [Related]  

  • 6. Varicella vaccination: where do we go from here?
    Brunell PA
    Hosp Pract; 1980 Sep; 15(9):91-3, 97, 100-1 passim. PubMed ID: 6250972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Failure of varicella-zoster immunoglobulin in modification of severe congenital varicella.
    Bakshi SS; Miller TC; Kaplan M; Hammerschlag MR; Prince A; Gershon AA
    Pediatr Infect Dis; 1986; 5(6):699-702. PubMed ID: 3025821
    [No Abstract]   [Full Text] [Related]  

  • 8. [Varicella zoster immunoglobulin. Prophylactic use in risk patients].
    Geursen RG
    ZFA (Stuttgart); 1983 Mar; 59(7):342-7. PubMed ID: 6303013
    [No Abstract]   [Full Text] [Related]  

  • 9. Prevention and treatment of varicella-zoster virus infection.
    Gershon AA
    Pediatr Infect Dis; 1984; 3(3 Suppl):S34-6. PubMed ID: 6204323
    [No Abstract]   [Full Text] [Related]  

  • 10. Zoster immune plasma prophylaxis of varicella: a follow-up report.
    Balfour HH; Groth KE
    J Pediatr; 1979 May; 94(5):743-6. PubMed ID: 221631
    [No Abstract]   [Full Text] [Related]  

  • 11. [Chickenpox prevention in patients at risk with a special immunoglobulin].
    Thomas E; Enders-Ruckle G; Geursen RG
    Klin Padiatr; 1985; 197(5):415-8. PubMed ID: 2999501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The protective value of varicella-zoster immunoglobulin in the hospital environment].
    Puvacić Z; Naumović M; Puvacić B; Hadimujić I; Prekajski D; Bosković R
    Med Arh; 1983; 37(3):139-42. PubMed ID: 6400849
    [No Abstract]   [Full Text] [Related]  

  • 13. Varicella zoster immunoglobulin after postnatal exposure to varicella: survey of experts.
    Wurzel CL; Rubin LG; Krilov LR
    Pediatr Infect Dis J; 1987 May; 6(5):466-70. PubMed ID: 3037474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Towards evidence based medicine for paediatricians. How effective is varicella-zoster immunoglobulin (VZIG) in preventing chickenpox in neonates following perinatal exposure?
    Tebruegge M; Pantazidou A; Curtis N
    Arch Dis Child; 2009 Jul; 94(7):559-61. PubMed ID: 19542068
    [No Abstract]   [Full Text] [Related]  

  • 15. Varicella zoster immunoglobulin to prevent neonatal chickenpox.
    Bose B; Kerr M; Brookes E
    Lancet; 1986 Feb; 1(8478):449-50. PubMed ID: 2868370
    [No Abstract]   [Full Text] [Related]  

  • 16. [Use of specific intravenous varicella-zoster immunoglobulins in the prevention of varicella in immunocompromised children: clinical and serological evaluation].
    Macchia P; Favre C; Nardi M; Consolini R; Conaldi PG; Bendinelli M
    Minerva Pediatr; 1987 Oct; 39(20):813-20. PubMed ID: 2830480
    [No Abstract]   [Full Text] [Related]  

  • 17. PROTECTIVE LEVELS OF VARICELLA-ZOSTER ANTIBODY DID NOT EFFECTIVELY PREVENT CHICKENPOX IN AN X-LINKED AGAMMAGLOBULINEMIA PATIENT.
    Nobre FA; Gonzalez IG; de Moraes-Pinto MI; Costa-Carvalho BT
    Rev Inst Med Trop Sao Paulo; 2015; 57(5):455-7. PubMed ID: 26603238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Varicella-zoster immune globulin--United States.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1981 Jan; 30(2):15-6, 21-3. PubMed ID: 6789088
    [No Abstract]   [Full Text] [Related]  

  • 19. VariZIG for prophylaxis after exposure to varicella.
    Med Lett Drugs Ther; 2006 Aug 14-28; 48(1241-1242):69-70. PubMed ID: 16977283
    [No Abstract]   [Full Text] [Related]  

  • 20. VZV infection in pregnancy: a retrospective review over 5 years in Sheffield and discussion on the potential utilisation of varicella vaccine in prevention.
    McKendrick MW; Lau J; Alston S; Bremner J
    J Infect; 2007 Jul; 55(1):64-7. PubMed ID: 17418420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.